Effect of Dapagliflozin/Metformin XR vs Monotherapies on Anthropometric Indicators in Obesity

NCT03710460 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Dapagliflozin
DRUG: Dapagliflozin plus Metformin XR
DRUG: Metformin XR

Sponsor

University of Guadalajara